What is XYMOGEN?
Founded in 1990 and headquartered in Florida, XYMOGEN operates as a family-owned health sciences entity. The company is dedicated to the provision and manufacturing of high-quality dietary supplements and functional foods. Its long-standing history in the industry positions it as a reliable provider within the competitive health and wellness market. The company's operational focus on both manufacturing and product development allows for a vertically integrated approach to its offerings.
How much funding has XYMOGEN raised?
XYMOGEN has raised a total of $7.4M across 5 funding rounds:
Private Equity
$550K
Private Equity
$656K
Private Equity
$2.8M
Unspecified
$1.4M
Debt
$2M
Private Equity (2004): $550K, investors not publicly disclosed
Private Equity (2005): $656K, investors not publicly disclosed
Private Equity (2011): $2.8M, investors not publicly disclosed
Unspecified (2011): $1.4M featuring Undisclosed
Debt (2020): $2M backed by PPP
Key Investors in XYMOGEN
PPP
Public-Private Partnership
What's next for XYMOGEN?
The recent major strategic investment in XYMOGEN suggests a trajectory aimed at scaling operations, expanding product lines, or enhancing market reach. Given the company's established enterprise-level funding context, this capital infusion is likely to fuel further innovation in its health sciences and dietary supplement offerings. Future strategic initiatives may involve research and development into new functional food categories or broader distribution channels to capitalize on the growing consumer demand for health-focused products.
See full XYMOGEN company page
